Study Stopped
The study was terminated because of difficulty in completing the study as originally planned
Endoscopic Biliary Drainage in Malignant High Grade Biliary Stricture
Endoscopic Retrograde Cholangiopancreatography Versus Endoscopic Ultrasound Guided Biliary Drainage in Inoperable Malignant Distal Bile Duct Obstruction
1 other identifier
interventional
10
1 country
2
Brief Summary
Biliary drainage is the mainstay of the palliative treatment in patients with inoperable malignant bile duct stricture. Endoscopic retrograde cholangiopancreatography (ERCP) is the cornerstone of biliary drainage method in these patients. However, ERCP is sometime unsuccessful to perform because of the presence of the high grade biliary stricture, tumor invasion of duodenum and ampulla of vater and surgically altered gastrointestinal anatomy. Endoscopic ultrasound (EUS) guided biliary drainage has been emerged as an alternative procedure to traditional surgical bypass and percutaneous trans hepatic biliary drainage after failed ERCP. There were few data to directly compare between ERCP and EUS guided biliary drainage and in patients with malignant high grade biliary stricture.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2018
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 8, 2018
CompletedFirst Posted
Study publicly available on registry
May 21, 2018
CompletedStudy Start
First participant enrolled
August 20, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 28, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2019
CompletedApril 1, 2021
March 1, 2021
3 months
May 8, 2018
March 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Technical success rate
The number of patients with success of placement of stent in the desired. location
24 hours
Secondary Outcomes (5)
Clinical success rates
2 weeks
Total procedure time
24 hours
The complication rates
4 weeks
The mortality rates
1 weeks
Stent patency
12 weeks
Study Arms (2)
ERCP with biliary stenting
ACTIVE COMPARATORPatient will be undergone ERCP with biliary stenting for biliary decompression to relieve biliary obstruction.
EUS guided biliary drainage
ACTIVE COMPARATORPatient will be undergone EGBD for biliary decompression to relieve biliary obstruction.
Interventions
ERCP with biliary stent is performed using a side view duodenoscope of Olympus (TJF-160). Biliary cannulation is performed using a sphincterotome and 0.035 inch jag wire, and cholangiogarm is done to assess common bile duct diameter, and length of biliary stricture. Biliary sphincterotomy is then performed. A straight biliary stent is placed across stricture bile duct.
EUS guided biliary drainage is performed using a linear echoendoscope of Olympus (GFUCT240). Extrahepatic bile duct was identified from duodenal bulb, then 19 G needle is inserted into bile duct with confirmed with cholangiogram. The fistula tract is dilated using a 6 Fr cystotome (Wilson Cook Medical). A double pigtail stent is placed across biliary-enteric fistula.
Eligibility Criteria
You may qualify if:
- distant metastasis
- major vascular involvement (unreconstructible Superior mesenteric vein/Portal vein, superior mesenteric artery, common hepatic artery and celiac artery)
- metastasis to lymphnode beyond the field or surgery IV) Jaundice, total bilirubin ≥15 mg/dl and/ or Common bile duct diameter ≥12 mm
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
NKC Institue of Gastroenterology and Hepatology, Prince of Songkla University
Hat Yai, Changwat Songkhla, 90110, Thailand
Prince of Songkla University
Hat Yai, Changwat Songkhla, 90230, Thailand
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nisa Netinatsunton, MD.
NKC Institute of Gastroenterology and Hepatology, Faculty of Medicine, Prince of Songkla University, Hatyai, Songkhla, Thailand, 90110.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Secretory of NKC Institute of Gastroenterology and Hepatology
Study Record Dates
First Submitted
May 8, 2018
First Posted
May 21, 2018
Study Start
August 20, 2018
Primary Completion
November 28, 2018
Study Completion
December 15, 2019
Last Updated
April 1, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share
The individual data of patients participating in the study are not available for public sharing since the investigators did not obtain the consent to share the data of patient.